PINIT study

PINIT study (screening and recruitment completed)

The PINIT study aims to prevent or delay the development of beta-cell autoimmunity and diabetes in children with a high genetic risk of type 1 diabetes. Participating children aged 1-7 years receive insulin or placebo by nasal spray application, daily for seven consecutive days and one day per week thereafter for 6 months.

Information flyer for download